Drug
Dipropizine clinical trials
Also written Levodropropizine.
- studies test it
- 6
- open now
- 1
- in phase 3
- 3
- first study started
- 2011
Keep track of what changes. Save the dipropizine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 3
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Pontificia Universidad Catolica de Chile (1) · Dompé Farmaceutici S.p.A (1) · Hyundai Pharm (1) · Hanmi Pharmaceutical Company Limited (1) · Pharmbio Korea Co., Ltd. (1) · Ache Laboratorios Farmaceuticos S.A. (1)
Often tested with
Tested in the same studies.
Codeine (1) · Ambroxol (1) · Diphenhydramine (1) · Pseudoephedrine (1)
Studies
Open first, then newest update. How each study uses dipropizine is read from its arms, and is right about nine times in ten.
Testing it · 6
- Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy AdultsRecruitingPhase 1Pharmbio Korea Co., Ltd.NCT07161180Written as R1_PBK_M2301 (levodropropizine)
- CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOSCompletedPhase 4Pontificia Universidad Catolica de ChileNCT06907355Written as Levodropropizine
- Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry CoughCompletedPhase 3Dompé Farmaceutici S.p.ANCT03837938Written as Levopront® syrup 30 mg/5 ml
- Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic BronchitisCompletedPhase 3Hyundai PharmNCT03489837Written as Levotuss
- Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute RhinitisWithdrawnPhase 3Ache Laboratorios Farmaceuticos S.A.NCT01177852Written as diphenhydramine + dropropizine + pseudoephedrine
- A Drug-Drug Interaction Study of Ambroxol and LevodropropizineCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT01573663Written as Ambroxol and Levodropropizine
Given in every arm · 1 — dipropizine is usual care beside what is tested
As the comparator · 1 — what is tested is compared with dipropizine
Codes
What other systems call dipropizine · ClinicalTrials.gg INT003057
- MeSH (NLM) C035916dipropizineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3O31P6T4G3LEVODROPROPIZINEConfirmed FDA, NLM
- RxNorm 52014One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C035916 | dipropizine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3O31P6T4G3 | LEVODROPROPIZINE | Confirmed FDA, NLM |
| RxNorm | 52014 | — | One source FDA |
Also registered as dropropizine (UNII U0K8WHL37U · RxNorm 23419).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.